|Last: || $3.330|
|Volume: || 17,446|
As Of: 2014-03-10 23:09:52 ET
*Quotes delayed by 20min.
Transcept Pharmaceuticals Inc (NASDAQ:TSPT)
Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of proprietary products that address therapeutic needs in the field of neuroscience. Its principal product comprises Intermezzo sublingual tablet C-IV, a sublingual formulation of zolpidem for the treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep. The company has a collaboration agreement with Purdue Pharmaceutical Products, L.P. for the commercialization of Intermezzo in the United States, as well as granted Purdue Pharmaceutical Products, L.P. the right to negotiate for the commercialization of Intermezzo in Mexico and Canada. Transcept Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Point Richmond, California.